Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-04-09 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2018年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the period January 1, 2018 to March 31, 2018, indicating expected net profit growth and providing explanations for the changes. It explicitly states that the financial data is preliminary and unaudited, and that detailed financial data will be disclosed in the company's 2018 first quarter report. The document is short (1245 characters) and serves as an earnings preview rather than a full financial report. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results highlights.
2018-04-09 Chinese
第三届监事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 15th meeting of the third Supervisory Board of the company SanNuo Biological Sensor Co., Ltd. It details the meeting attendance, the agenda, and the voting results on a specific transaction involving acquisition of equity shares. The document is an official disclosure of board-level decisions, specifically from the Supervisory Board, and includes information about related party transactions and compliance with stock exchange rules. It does not contain financial statements, audit opinions, or detailed financial results. It is not a full annual or interim report, nor is it a call transcript or earnings release. It is not a proxy solicitation or voting results announcement. The content fits best under Board/Management Information (MANG) as it announces decisions made by the company's supervisory board regarding management-level corporate actions.
2018-04-09 Chinese
独立董事关于拟收购资产暨关联交易的事前认可函
Regulatory Filings Classification · 95% confidence The document is a letter from independent directors providing prior approval for a proposed asset acquisition and related party transaction. It discusses the terms of the acquisition, compliance with laws and regulations, fairness of the transaction, and the board's review process. There are no financial statements or comprehensive financial data presented. The document is a formal approval letter related to a transaction, not a full report or announcement of financial results. It fits best under the category of Regulatory Filings (RNS) as it is a compliance-related disclosure about a transaction and board approval, without being a full report or announcement of a financing or capital change.
2018-04-09 Chinese
独立董事关于公司第三届董事会第二十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a specific transaction discussed at a board meeting, specifically regarding the company's acquisition of partial equity in another company. It references compliance with regulatory guidelines and internal governance rules, and it includes signatures of independent directors. The document is not a full financial report, earnings release, or regulatory filing but rather a formal opinion related to a board decision on a transaction. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions involving the board or senior management, including opinions on significant transactions.
2018-04-09 Chinese
独立董事关于公司第三届董事会第二十次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's board meeting, specifically regarding the second revision of the first employee stock ownership plan. It references compliance with relevant laws and regulations and confirms the legality and appropriateness of the plan revision. The document is a formal opinion statement by independent directors rather than a full financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. It is not an announcement of voting results or a proxy solicitation. The content aligns with Board/Management Information (MANG) as it relates to board meeting matters and governance opinions on company plans.
2018-04-02 Chinese
第一期员工持股计划（二次修订稿）摘要
Regulatory Filings Classification · 95% confidence The document is titled as an employee stock ownership plan (员工持股计划) for 三诺生物传感股份有限公司, detailing the plan's purpose, funding sources, stock acquisition methods, participants, lock-up periods, and governance. It references relevant Chinese laws and regulations governing employee stock ownership plans and includes detailed operational and procedural information. There is no indication that this is a financial report, earnings release, or regulatory filing announcement. Instead, it is a comprehensive plan document outlining the structure and rules of the employee stock ownership plan. This type of document fits best under the category of Regulatory Filings (RNS) because it is a regulatory disclosure about the employee stock ownership plan, not a financial report or announcement of voting results or capital changes. It is not a proxy solicitation or remuneration report either. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2018-04-02 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.